n. (%) | |
---|---|
Total number of patients | 100 |
Age | |
< 61 | 55 (55) |
≥ 61 | 45 (45) |
Clinical Stage | |
I, II | 38 (38) |
III, IV | 62 (62) |
Performance status | |
0–1 | 77 (77) |
2–4 | 23 (23) |
LDH | |
N≥ | 52 (52) |
N < | 48 (48) |
Extranodal lesion | |
0–1 | 68 (68) |
2–4 | 32 (32) |
IPI | |
Low/low-intermediate | 58 (58) |
High/high-intermediate | 42 (42) |
Albumin | |
< 3.5 g/dl | 26 (26) |
≥3.5 g/dl | 74 (74) |
Prophylactic G-CSF | |
yes | 62 (62) |
no | 38 (38) |